Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice

Published:2024-08 Issue:8 Volume:14 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Sailor‐Longsworth Emma J.¹,Lutze Richard D.¹,Ingersoll Matthew A.¹,Kelmann Regina G.¹,Ly Kristina¹,Currier Duane²,Chen Taosheng²,Zuo Jian³,Teitz Tal¹⁴^ORCID

Affiliation:

1. Department of Pharmacology and Neuroscience School of Medicine Creighton University Omaha Nebraska USA

2. Department of Chemical Biology and Therapeutics St. Jude Children's Research Hospital Memphis Tennessee USA

3. Department of Biomedical Sciences School of Medicine Creighton University Omaha Nebraska USA

4. The Scintillon Research Institute San Diego California USA

Funder

U.S. Department of Defense

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1803

Reference10 articles.

1. IngersollMA MalloyEA CasterLE et al.BRAF inhibition protects against hearing loss in mice.Sci Adv.2020;6(49):eabd0561. doi:10.1126/sciadv.abd0561PMID: 33268358; PMCID: PMC7821884

2. CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss

3. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP